Results 41 to 50 of about 98,054 (191)
Human Vaccines & Immunotherapeutics, 2020 Objective To evaluate the cost-effectiveness of the current strategy combining universal vaccination with hepatitis B immunoglobulin (HBIG) treatment for infants of hepatitis B surface antigen (HBsAg) positive mothers compared with universal vaccination ...
Yanbing Zeng +6 more
doaj +1 more source
Abandoning Eugenics and the QALY
INNOVATIONS in Pharmacy, 2021 Should decision making in health care, notably in respect of the allocation of resources between individuals and disease states, rest on notions of the burden of disease and denial of care as assessed by societal evaluations or on the extent to which the
Paul C Langley
doaj +1 more source
Value in Health, 2009 In the preceding article, Weinstein et al. [1] explain the QALYconcept, its methods, and their underlying assumptions. Anumber of interesting themes for discussion arise from thisfactual presentation. We restrict ourselves to addressing fourissues that we deem particularly challenging.As a general background for our selection of issues, we reit-erate a
Nord, Erik +2 more
openaire +2 more sources
Journal of Pain Research, 2020 Thomas G Poder,1– 3 Nathalie Carrier3 1School of Public Health, Department of Management, Evaluation and Health Policy, University of Montreal, Montreal, QC, Canada; 2Centre de recherche de l’Institut universitaire en santé mentale de ...
Poder TG, Carrier N
doaj
Фармакоэкономика, 2015 Utility assessment is one of the most important stages of pharmacoeconomic analysis. Most of utility researches are conducted using standard gamble method which is considered the classic instrument of health state utilities assessment.
R. I. Yagudina +2 more
doaj
ClinicoEconomics and Outcomes Research, 2021 Marco Bellone,1 Lorenzo Pradelli,1 Stefano Molica,2 Adele Emanuela De Francesco,3 Daniela Ghislieri,4 Emanuele Guardalben,5 Antonietta Caputo4 1Department of Health Economics and Outcome Research, AdRes Health Economics and Outcomes Research, Turin ...
Bellone M +6 more
doaj
Review of methods for assessing the cost-effectiveness of medical interventions
Реальная клиническая практика: данные и доказательстваAssessment of the effectiveness of a drug is a complex process. Currently, the standard method for assessing the effectiveness of a medical intervention is the quality-adjusted life years (QALY).
T. I. Busheva, A. A. Kurylev
doaj +1 more source
Health and Quality of Life Outcomes, 2017 BackgroundHealthcare interventions that have positive effects on the stroke survivors’ health-related quality of life (HRQoL) and quality-adjusted life-years (QALYs) might also have positive effects for their spouses in terms of improved HRQoL and/or ...
Josefine Persson +7 more
semanticscholar +1 more source
Journal of Medical Ethics, 1989 The ethical problem of how to apportion limited resources amongst the needy has been forced on us by arbitrary limitation of health expenditure. Its solution would not be required if health expenditure were higher. Distribution of resources according to best value for money, assessed as Quality Adjusted Life Years (QALYs) per unit cost, has been ...
openaire +2 more sources
Health and Quality of Life Outcomes, 2015 Measuring health and health-related quality of life (HRQoL) is important for tracking the health of individuals and populations over time. Generic HRQoL measures allow for comparison across health conditions. One form of generic HRQoL measures are profile measures, which provide a description of health across several different domains (such as physical
Janel Hanmer +9 more
openaire +4 more sources